Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies

Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted therapies for autoimmune disorders.

Curaleaf Q1 Revenue Falls 2% Sequentially

Curaleaf Reports First Quarter 2023 Results First quarter 2023 revenue of $336.5 million, representing an increase of 14% year-over-year, and adjusted EBITDA(1) of $73.2 million Operating cash flow from continuing operations of $30.6 million

May 18, 2023

Opinion | What the Matthew Perry Tragedy Reminds Us About Ketamine Use

Dayal is an anesthesiologist. “I’ll Be There For You,” the iconic theme song of the TV show “Friends,” is fondly etched in our memories, along

August 30, 2024

Immuno-Oncology related patent filings increased in the pharmaceutical industry in Q2 2023

Notably, the number of immuno-oncology-related patent applications in the pharmaceutical industry was 182 in Q2 2023, versus 170 in the prior quarter. The top five

August 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.